Short-term and long-term outcomes of revascularization interventions for patients with severely reduced left

Junyu Pei1, Xiaopu Wang1, Zhenhua Xing1,2

  • 1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, Hunan, 410011, China.

ESC Heart Failure
|December 4, 2020
PubMed

Insights

Coronary artery bypass grafting (CABG) offers lower long-term mortality for patients with reduced ejection fraction compared to percutaneous coronary intervention (PCI). However, CABG is linked to an increased risk of stroke, particularly long-term.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Severely reduced left ventricular (LV) ejection fraction poses significant risks for patients with coronary artery disease.
  • Choosing between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) is critical for this patient group.

Purpose of the Study:

  • To compare the effectiveness of CABG versus PCI in patients with severely reduced LV ejection fraction.
  • To evaluate long-term mortality, myocardial infarction (MI), stroke, and repeat revascularization rates for both procedures.

Main Methods:

  • A meta-analysis of 18 studies involving 11,686 patients.
  • Searched PubMed, EMBASE, and Cochrane Library databases up to May 1, 2020.
  • Primary endpoints: 30-day and long-term mortality. Secondary endpoints: MI, stroke, cardiovascular mortality, and repeat revascularization.

Main Results:

  • CABG demonstrated lower long-term mortality, cardiovascular mortality, MI, and repeat revascularization compared to PCI.
  • No significant difference in 30-day mortality or long-term stroke risk was observed initially.
  • However, CABG was associated with a higher risk of 30-day stroke and, in subgroup analysis, a higher long-term stroke risk.

Conclusions:

  • For patients with severely reduced LV ejection fraction, CABG leads to reduced mortality rates.
  • The benefit of CABG in terms of mortality must be weighed against its associated increased risk of stroke.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
100
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
141
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
187